Bromelain, fruit
CAS 9001-00-7
Bromelain, fruit (CAS 9001-00-7) is a pharmaceutical compound with 0 bioactivity targets and 102 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Bromelain, fruit is linked to DTXSID901010881 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bromelain, fruit used for in pharmaceutical contexts?
Bromelain, fruit (CAS 9001-00-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bromelain, fruit?
Bromelain, fruit has 102 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Application site haemorrhage, Back pain, Biliary cyst, Blister. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bromelain, fruit also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Bromelain with EU status "permitted".
What clinical phase is Bromelain, fruit in?
No phase 1-4 clinical development badge is rendered for Bromelain, fruit because the matched compound identifier rows do not contain a max-phase value.